| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 02/18/1999 | CA2299411A1 Heparin-binding growth factor (hbgf) polypeptides |
| 02/18/1999 | CA2299226A1 Tango-71, tango-73, tango-74, tango-76, and tango-83 nucleic acid molecules and polypeptides |
| 02/18/1999 | CA2298849A1 Lipoprotein-regulating medicaments |
| 02/18/1999 | CA2298439A1 Lipocalin homologs |
| 02/18/1999 | CA2297736A1 Treatment of acute lung injury and fibrosis with antagonists of .alpha.v.beta.6 |
| 02/18/1999 | CA2296598A1 Isolation of a novel senescence-factor gene, p23 |
| 02/18/1999 | CA2274302A1 Lsr receptor, activity, cloning, and uses for diagnosing, preventing and/or treating obesity and related risks or complications |
| 02/17/1999 | EP0897011A2 Novel arginine deiminase |
| 02/17/1999 | EP0897007A2 MraY transferase |
| 02/17/1999 | EP0897004A2 Histidyl tRNA synthetase from Streptococcus pneumoniae (hisS) |
| 02/17/1999 | EP0897001A1 Polypeptide having a GTPase regulator activity, nucleic acids coding therefore and their use in diagnostics and therapy |
| 02/17/1999 | EP0896626A1 Monoclonal antibody to cea, conjugates comprising said antibody, and their therapeutic use in an adept system |
| 02/17/1999 | EP0896623A1 Immunity to trypanosomatids species |
| 02/17/1999 | EP0896622A1 Chemokine alpha 2 |
| 02/17/1999 | EP0896615A1 Peptide from soluble form of acetylcholinesterase, active as a calcium channel modulator |
| 02/17/1999 | EP0896586A1 ErbB3 ANTIBODIES |
| 02/17/1999 | EP0896585A1 Humanized anti-cd40 monoclonal antibodies and fragments capable of blocking b cell activation |
| 02/17/1999 | EP0896584A2 BIOLOGICALLY ACTIVE PROTEIN (COLLAGEN FRAGMENT HF-COLL-18/514cf) FOR INHIBITING THE GROWTH OF TUMOURS AND CAPILLARY PROFILERATIONS |
| 02/17/1999 | EP0896545A1 Drug containing hcv hyperimmune globulins |
| 02/17/1999 | EP0896542A1 Method of restoring a functional protein in a tissue by cell transplantation |
| 02/17/1999 | EP0728016B1 Use of anti-idiotypic antibodies to prevent hyperacute rejection of xenografts |
| 02/17/1999 | CN1208420A Antisecretory factor peptides regulating pathological permeability changes |
| 02/17/1999 | CN1207946A Thioether conjugates |
| 02/16/1999 | US5872235 Nucleic acids encoding tumor marker |
| 02/16/1999 | US5872231 Nucleic acids encoding merosin |
| 02/16/1999 | US5872226 Fibroblast growth factor homologous factor-1 (FHF-1) |
| 02/16/1999 | US5872223 Immunoconjugates comprising tyrosine kinase inhibitors |
| 02/16/1999 | US5872222 Conjugate comprises nonimmunogenic polymer coupled with a plurality of binding molecules, each being specific for an antigen on a t cell, and binding molecule lacking an fc portion |
| 02/16/1999 | US5872221 Capable of binding epitopes of pthrp and a kit for the detection of pthrp or fragments thereof comprising one or more antibody reagents capable of binding to epitopes of pthrp |
| 02/16/1999 | US5872220 Antibodies to insulin-like growth factor binding protein IGFBP-6 |
| 02/16/1999 | US5872219 Antibodies drawn to the eps15 substrate for epidermal growth factor receptor kinase |
| 02/16/1999 | US5872218 Monoclonal antibodies |
| 02/16/1999 | US5872217 Antibodies which specifically bind a cancer related antigen |
| 02/16/1999 | US5872215 Specific binding members, materials and methods |
| 02/16/1999 | US5872212 Pesticidal proteins and strains |
| 02/16/1999 | US5872209 Artificial recombinant substrate (rAGG 1) and native aggrecan to determine the proteolytic activity of `aggrecanase` in cell culture systems |
| 02/16/1999 | US5872095 IL-1 receptor antagonists medicaments |
| 02/16/1999 | US5872012 Protamine-reactive IGM antibodies |
| 02/16/1999 | US5871997 A gene therapy treating with a glycolytic enzyme |
| 02/16/1999 | US5871974 Recombinant expression of heteromeric receptors on the surface of filamentous bacteriophage |
| 02/16/1999 | US5871973 Cell division regulators |
| 02/16/1999 | US5871970 Calcium-binding protein |
| 02/16/1999 | US5871939 Agents and method for identifying insects |
| 02/16/1999 | US5871936 Detection and treatment of breast cancer using monoclonal antibodies produced by hybridoma formed by fusing mouse lymphocytes and myeloma cells; solid tumor shrinkage |
| 02/16/1999 | US5871934 Screening methods using cytokine suppressive anti-inflammatory drug (CSAID) binding proteins |
| 02/16/1999 | US5871933 Diagnosing, screening, and confirming infection with accuracy; vaccines |
| 02/16/1999 | US5871931 Methods for detecting mammalian tub protein and RNA |
| 02/16/1999 | US5871930 High affinity immunoglobulin E receptor-like protein |
| 02/16/1999 | US5871907 Methods for producing members of specific binding pairs |
| 02/16/1999 | US5871904 Immunassay of non-A, non-B hepatitis virus-related antigens, monoclonal antibodies for use therein, and hybridomas producing the antibodies |
| 02/16/1999 | US5871748 Administering to the subject a vaccine complex comprising a live vaccine virus and antibodies bound to said live vaccine virus |
| 02/16/1999 | US5871739 Pharmaceutical composition |
| 02/16/1999 | US5871738 Nematode vaccine |
| 02/16/1999 | US5871737 Methods for treating a fibrin encapsulated tumor using a fibrin specific monoclonal antibody and compositions used therein |
| 02/16/1999 | US5871735 Isoferritin as a marker for pathological pregnancy |
| 02/16/1999 | US5871734 Treatment for asthma with VLA-4 blocking agents |
| 02/16/1999 | US5871732 Dna sequences and genetic engineering for aids |
| 02/16/1999 | US5871731 Oral administration of immunoglobulin preparations for treatment of chronic pain syndrome |
| 02/16/1999 | US5871729 Superoxide dismutase-4 |
| 02/16/1999 | US5871727 Targeted adenovirus vectors |
| 02/16/1999 | US5871724 Administering to the subject an amount of a transforming growth factor beta 3 effective to slow the growth of normal cells |
| 02/16/1999 | US5871712 Neurodegenerative condition, antiischemic agents and antibodies |
| 02/16/1999 | CA2122112C Adrenomedullin |
| 02/16/1999 | CA2000913C Family of high affinity antibodies for cancer treatment |
| 02/16/1999 | CA1340397C Method of preparation and use for zona pellucida antigens and antibodies for sterilization and contraception |
| 02/16/1999 | CA1340391C Monoclonal antibodies against atrial, natriuretic peptides of humans |
| 02/15/1999 | CA2224096A1 The g-protein coupled receptor hfia041 |
| 02/14/1999 | CA2239264A1 Novel uses |
| 02/13/1999 | CA2240637A1 Novel ratb |
| 02/13/1999 | CA2240627A1 Novel ratc |
| 02/13/1999 | CA2240623A1 Novel rata |
| 02/12/1999 | CA2239837A1 Novel murd |
| 02/12/1999 | CA2239835A1 Human sdr2 cdna clone |
| 02/12/1999 | CA2231728A1 Mray |
| 02/11/1999 | WO1999006840A1 Collagen-peptide assay method |
| 02/11/1999 | WO1999006837A1 Method for detecting hbcag from hepatitis b virus |
| 02/11/1999 | WO1999006834A2 Methods for identifying ligand specific binding molecules |
| 02/11/1999 | WO1999006833A1 Methods for obtaining probes of peptide function |
| 02/11/1999 | WO1999006599A1 Synthetic antigen for the detection of antibodies immunoreactive with hiv virus |
| 02/11/1999 | WO1999006577A2 Agent for expressing and detecting a fusion polypeptide with an hpol-epitope and a polypeptide |
| 02/11/1999 | WO1999006575A1 Starch debranching enzymes |
| 02/11/1999 | WO1999006572A1 Synaptojanin isoform |
| 02/11/1999 | WO1999006563A1 Novel bone mineralization proteins, dna, vectors, expression systems |
| 02/11/1999 | WO1999006561A2 Chemokine receptor ccr8 dna and uses thereof |
| 02/11/1999 | WO1999006558A1 Human longevity-assurance protein homologs |
| 02/11/1999 | WO1999006557A2 Mammalian cell membrane proteins; related reagents |
| 02/11/1999 | WO1999006545A2 Composition and method for the detection of diseases associated with amyloid-like fibril or protein aggregate formation |
| 02/11/1999 | WO1999006541A1 Antihuman pre-b cell receptor antibodies |
| 02/11/1999 | WO1999006539A1 Zggbp1, novel peptides related to bipolar affective disorder type 1, sequences and uses thereof |
| 02/11/1999 | WO1999006536A1 Catalytic monoclonal antibodies for the in vivo transformation of corticosteroid prodrugs |
| 02/11/1999 | WO1999006442A1 EPO PRIMARY RESPONSE GENE, EPRG3Spt |
| 02/11/1999 | WO1999006428A1 Tango-72 and tango-77 nucleic acid molecules and polypeptides |
| 02/11/1999 | WO1999006427A1 Tango-78, tango-79, and tango-81 nucleic acid molecules and polypeptides |
| 02/11/1999 | WO1999006426A1 Novel molecules of the tango-77 related protein family and uses thereof |
| 02/11/1999 | WO1999006425A1 Oxidized styrenic polymers for dna binding |
| 02/11/1999 | WO1999006423A1 83 human secreted proteins |
| 02/11/1999 | WO1999006068A2 Recombinant dimeric envelope vaccine against flaviviral infection |
| 02/11/1999 | WO1999006066A2 Catalytic monoclonal antibodies with protease activity for the selective lysis of the protein component of plaques and aggregates related to pathological conditions |
| 02/11/1999 | WO1999006063A1 EPO PRIMARY RESPONSE GENE, EPRG3pt |
| 02/11/1999 | WO1998044948A3 Intravenous immune globulin formulation containing a non-ionic surface active agent with improved pharmacokinetic properties |